Cats, beloved companions to millions, often enjoy close interactions with their owners, from playful cuddles to snuggly naps. While these interactions are what make us love cats most, they also present potentially dangerous opportunities for the transmission of pathogenic bacteria between humans and animals, a process known as zoonotic transmission. One bacterium of particular concern is Streptococcus canis (S. canis), a pathogen that has been linked to serious health issues in humans, such as endocarditis, necrotizing fasciitis, and septicemia, all potentially life-threatening conditions! Traditionally, S. canis has been associated with the mouths, ears, and rectums of cats, but new research has revealed that this bacterium can also colonize the skin, broadening the potential for zoonotic transmission.

Recently, our research team at MiDOG presented a study at the International Society of Companion Animal Infectious Disease (ISCAID) Conference in Vancouver investigating the presence of S. canis and other Streptococcus species on the skin microbiome of cats. By utilizing next-generation sequencing (NGS), we aimed to uncover how the bacterial landscape differed between cats in various health conditions and what implications these findings might have for veterinary care and pet owners.

Background on Streptococcus canis and Zoonotic Transmission

Streptococcus canis is a Gram-positive bacterium that belongs to the larger Streptococcus genus, known for its role in various infections in both animals and humans. In veterinary medicine, S. canis is most frequently associated with infections in dogs and cats, causing conditions such as wound infections, respiratory disease, and even fatal septicemia in severe cases. However, the zoonotic potential of S. canis makes it particularly noteworthy. Transmission from animals to humans typically occurs through direct contact, particularly when the skin barrier is broken, such as in the case of scratches, bites, or open wounds.

Until recently, the focus on S. canis zoonotic transmission centered on its presence in mucosal areas like the mouth and ears of cats. However, given that pet owners frequently handle their cats’ fur and skin, we felt it important to investigate whether S. canis also resides on the skin microbiome.

Aims of the Study

The primary objective of this study was to identify various Streptococcus species present in the skin microbiome of cats, using NGS technology. By comparing the skin microbiome of healthy cats to that of unhealthy cats with various diseases, the researchers aimed to determine whether certain Streptococcus species, particularly S. canis, were more prevalent in unhealthy cats. Given that unhealthy cats might be more prone to bacterial imbalances or infections, the study sought to establish whether these cats had a higher concentration of S. canis, which could, in turn, affect their ability to transmit this bacterium to humans.

Methodology

We tested the skin microbiome of 139 cats in total—69 healthy and 70 unhealthy. The next-generation sequencing (NGS) technology we use regularly at MiDOG Animal Diagnostics was employed as the primary method for identifying the bacterial species. NGS is a powerful molecular tool that allows researchers to sequence DNA from complex samples, such as skin microbiomes, with high precision. This technology has revolutionized microbiome studies, enabling the detection of numerous bacterial species simultaneously and down to specific strains, which is critical for understanding how these bacteria interact with their hosts.

To ensure that the most relevant bacterial species were analyzed, only Streptococcus species found in at least 10% of the total population were included. This criterion led to the identification of 13 Streptococcus species that were subjected to further statistical analysis. The relative abundance of each species between healthy and unhealthy cats was compared using the non-parametric Wilcoxon signed-rank test.

Our study yielded several important findings:

  1. Prevalence of Streptococcus canis among both healthy and unhealthy cats: Among all the Streptococcus species identified, S. canis had the highest relative abundance in both healthy and unhealthy cats. However, there was a striking difference in its concentration between the two groups. In healthy cats, S. canis represented only a relative mean of 0.22% ± 1.3% standard deviation of the total skin microbiome. In contrast, unhealthy cats exhibited a significantly higher abundance of S. canis, accounting for a relative mean of 6.69% ± 24.22% standard deviation. This difference was statistically significant (P=0.027), highlighting a potential link between feline health status and the overgrowth of S. canis.
  2. Differences in Other Streptococcus Species: In addition to S. canis, three other Streptococcus species were found to be significantly more abundant in healthy cats. These included Streptococcus minor (P=0.017), Streptococcus mitis-oralis-pneumoniae (P=0.034), and an unidentified Streptococcus species (P=0.029). The higher prevalence of these species in healthy cats suggests that they may play a role in maintaining a balanced skin microbiome, potentially acting as protective agents against the overgrowth of pathogenic bacteria like S. canis.
  3. First Identification of S. canis on the Skin: Perhaps the most significant conclusion of this study is that it marks the first time S. canis has been identified as part of the skin microbiome in cats. This finding expands the understanding of where S. canis can colonize and brings about new questions about the role the skin plays in zoonotic transmission.

Implications for Veterinary Care and Pet Owners

For veterinarians and pet owners alike, these findings have important implications. The presence of S. canis on the skin, especially in unhealthy cats, suggests that pet owners who frequently handle their cats—particularly if their pets are ill—should be aware of the potential for transmission through direct skin contact. Owners with compromised immune systems, open wounds, or underlying health conditions should take extra precautions, including proper hand hygiene and possibly wearing gloves when treating or handling sick cats.

Veterinary professionals should consider including skin as part of the diagnostic workup for cats suspected of harboring S. canis, particularly if the animal is showing signs of illness. This expanded understanding of the skin microbiome can also lead to better strategies for managing infections in cats, potentially reducing the risk of zoonotic transmission.


Categories: Cats, Next-Gen DNA Sequencing Technology, Pet Health, Safety and Wellness, Pet Parents, Skin Health, Zoonotic Infections

animal diagnostics

Validated by Veterinarians

“Clients expect their veterinarians to stay up to date on all matters that affect the health and well being of their non-human family members. The current technique that we have used to determine the presence and antibiotic sensitivity of organisms causing disease in our pets is over a century old.

With the emergence of dangerous antibacterial resistance, it is critical that veterinarians are able to offer laser focused diagnostics and treatment. MiDog enables us to offer care that exceeds the typical standard of care.”

Bernadine Cruz, DVM, Laguna Hills Animal Hospital Laguna Woods, CA

“I love the absolute abundance and comparing the fungal with bacterial infection. I do not worry as much about getting a false negative urinary infection reading as I do with traditional urine cultures. Several times the same urine would culture negative but MiDOG would detect pathogens.”

Michael Morgan, DVMQuail Animal Hospital, Tustin, CA

“The MiDOG All-in-One Test is amazing, I would use it instead of culture and sensitivity.  Such rapid and detailed results, I will reach for MiDOG before culture next time!

Thank you very much MiDOG, for sharing the opportunity to try your technology.”

Martha Smith-Blackmore, DVM, President of Forensic Veterinary Investigations, LLC – Boston, MA

The MiDOG All-in-One Microbial Test is our new gold standard of pathogen identification. The results are so accurate and valuable – especially with assessing both bacterial and fungal infections with the same sample.

Thank you MiDOG!”

Kathy Wentworth, DVM, Diplomate ABVP Canine and Feline Practice – PetPoint Medical Center, Irvine, CA

“The MiDOG staff was extremely helpful and supportive.”

Cathy Curtis, DVM – London, UK

“I have had great results using the MiDOG® Test. Compared to traditional culture tests, I am better able to target the treatment for dogs because the MiDOG® Test is so sensitive that it identifies all pathogens including bacteria and fungi, as well as antibiotic sensitivity.

The cost and turnaround time are about the same as a culture test, but I get much more data. The test has great performance and I believe the NGS technology will be a game changer for veterinarians treating dogs with lesions or other infections.”

Michael Kavanagh, DVM, Practice owner – Saddleback Animal Hospital, Tustin, CA

“It’s helpful to have an NGS spectrum because it gives you a broader insight of what’s happening and what might be going on.”

Richard Harvey BVSc DVD DipECVD PhD FRSB FRCVS – European Specialist in Veterinary Dermatology – Head of Dermatology, Willows Veterinary Centre & Referral Service – Solihull, England UK

“I have been using MiDog for over 4 years now and exclusively as my test of choice for all cultures for 3 years.  It is so great to submit a culture and feel confident there will be a result when it comes back, especially for urine cultures.  The reports were intimidating at first because they contain so much information.  After the first few, I am now quickly able to glance over it and pick out the highlights.  I can then come back later and pour over all the details.  I have been extremely pleased with my patients’ results using the test as well.  I don’t envision ever going back to traditional culture and susceptibilities again.”

Brian M. Urmson, DVM, Columbiana Veterinary Associates

“As an exotic veterinarian, there are numerous tests we have to consider to check specific bacterial and fungal organisms based on the species. MiDOG eliminates the need for many of these separate samples and provides definitive results quickly to help us treat our patients more efficiently and effectively. The lab is wonderful to work with and has never rejected our samples- they even processed a lizard toe we amputated and determined the cause of skin infection.”

Dr. Melissa Giese, Chicago Exotics Animal Hospital

“MiDOG’s diagnostic approach offers the unique ability to identify pathogens that evade traditional culture and sensitivity testing. I have found that adding a molecular based testing approach in the form of Next Generation Sequencing (NGS) from MiDOG to my routine diagnostic cultures can be extremely helpful in the identification and diagnosis of uncommon pathogens in veterinary medicine.”

Dr. Wayne Rosenkrantz, Animal Dermatology Clinic – Tustin

“She [Dr. Krumbeck] really did a great job of making complicated concepts accessible and demonstrating the value of your services. I’m really looking forward to working with MiDOG on my research project!”

Dr. Yaicha Peters, Animal Dermatology Clinic – San Diego

“As a proud collaborator with MiDOG, I deeply appreciate their dedication to fostering partnerships between industry and veterinary experts. Their commitment to enhancing diagnostic quality for veterinarians is commendable. In my experience, their support has been invaluable, earning them a ‘Double A+, Triple Star’ rating. Their assistance has been faultless, contributing significantly to the success of my projects and studies. I eagerly anticipate our continued collaboration.”

Dr. Richard Harvey, BVSc DVD DipECVD PhD FRSB FRCVS; European Specialist in Veterinary Dermatology

“We’re seeing that, if we prescribe too many antibiotics or they’re taken too frequently, animals are developing inappropriate or pathogenic strains of bacteria. We’re also seeing that our antibiotics are just not working against them anymore… It’s a good example of why we need better diagnostic testing, like MiDOG, so that we’re selecting the correct antibiotic every time our patients have an infection.”

Dr. Alissa Rexo, DVM, CVA, DACVD, Mid-Atlantic Veterinary Dermatology

“The NGS technique as offered by MiDOG is wonderful because pathogens like Melissococcus plutonius, for example, are difficult to grow and keep alive in the laboratory. A standard laboratory cannot truly examine or even properly diagnose this pathogen in bee hives at this time. But with NGS, we can reliably diagnose it.”

Dr. Joerg Mayer, Entomologist and Microbiologist at the University of Georgia

“For me, as a clinician and as a researcher, I see the immense value in the product [the All-in-One Test]. I have had great success using MiDOG clinically, including identifying Mycoplasma in a 24 year old pigeon, a Nannizziopsis spp in a ball python from a large pet distributor, Mycoplasma and Fusobacterium necrophorum co-infection in a peacock, and to identify an abnormal gut GI in a technician’s dog that tested negative for everything else (but we were able to establish what was abnormal, and work toward fixing it).”

Dr. Jeremy Rayl – Veterinarian, Block House Creek Animal Hospital, Cedar Park, Texas

“With MiDog results I not only receive a list of organisms detected in the sample, but also cell counts which allow me to target the most abundant pathogens or the most pathogenic. The identification of antimicrobial resistance genes is also helpful in selecting an appropriate antibiotic. Another benefit is that sample handling is less prone to risk of overgrowth and is stable at room temperature. Easy and informative. A great tool in our diagnostic toolbox!!”

Lauren Palmer DVM, MPH, Marine mammal Care Center Los Angeles